AKT1 and non-small cell lung carcinoma: Flavokawain-B, a chalcone, showed potent anti-cancer effects in gemcitabine-resistant non-small-cell lung cancer (NSCLC) cells by inducing apoptosis and ROS production while inhibiting the PI3K/Akt signaling pathway [81].